XML 41 R30.htm IDEA: XBRL DOCUMENT v3.21.4
Derivative Liabilities and Fair Value Measurements (Tables)
 9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Derivative Liabilities And Fair Value Measurements [Abstract]    
Schedule of fair value on a recurring basis in the accompanying financial statements
   September 30,
2021		   Quoted Prices 
in Active 
Markets for 
Identical Assets
(Level 1)		   Significant 
Other 
Observable 
Inputs 
(Level 2)		   Significant 
Unobservable 
Inputs 
(Level 3)		 
Derivative liabilities  $4,289,634   $
             -
   $
                -
   $4,289,634 

 

   December 31,
2020		   Quoted Prices 
in Active 
Markets for 
Identical Assets
(Level 1)		   Significant 
Other 
Observable 
Inputs 
(Level 2)		   Significant 
Unobservable
Inputs 
(Level 3)		 
Derivative liabilities  $25,475,514   $
                       -
   $
                 -
   $25,475,514 

 
   December 31, 
2020		   Quoted Prices 
in Active 
Markets for 
Identical Assets
(Level 1)		   Significant 
Other 
Observable 
Inputs 
(Level 2)		   Significant 
Unobservable 
Inputs 
(Level 3)		 
Derivative liability  $25,475,514   $
        -
   $
               -
   $25,475,514 

 

   December 31,
2019		   Quoted Prices 
in Active 
Markets for 
Identical Assets
(Level 1)		   Significant 
Other 
Observable 
Inputs 
(Level 2)		   Significant 
Unobservable
Inputs 
(Level 3)		 
Derivative liability  $20,236,870   $
         -
   $
            -
   $20,236,870 

 
Schedule of changes in fair value of the company's level 3 financial liabilities
Balance, December 31, 2020  $25,475,514 
Transfers out due to conversions of convertible notes, accrued interest and warrants into shares of Series Y preferred stock   (4,834,911)
Transfers out due to conversions of convertible notes and accrued interest into shares of common stock   (118,778)
Transfers out due to cash payments made pursuant to settlement agreements   (175,565,103)
Change in derivative liability due to authorized shares shortfall   159,633,797 
Mark to market to September 30, 2021   (300,885)
Balance, September 30, 2021  $4,289,634 
      
Gain on change in derivative liabilities for the nine months ended September 30, 2021  $300,885 

 
Balance, December 31, 2018  $
-
 
Transfers in due to issuance of convertible notes and warrants with embedded conversion and reset provisions   686,059 
Transfers out due to conversions of convertible notes and accrued interest into common shares   (56,142)
Derivative liability due to authorized shares shortfall   18,921,538 
Mark to market to December 31, 2019   685,415 
Balance, December 31, 2019  $20,236,870 
Transfers in due to issuance of convertible notes and warrants with embedded conversion and reset provisions   573,230 
Transfers out due to conversions of convertible notes and accrued interest into common shares   (278,545)
Transfers out due to conversions of convertible notes, accrued interest and warrants into Series Y preferred shares   (165,826,982)
Derivative liability due to authorized shares shortfall   170,319,590 
Mark to market to December 31, 2020   451,351 
Balance, December 31, 2020  $25,475,514 
      
Loss on change in derivative liabilities for the year ended December 31, 2020  $(451,351)